Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure

ClinicalTrials.gov ID: NCT01944683

Public ClinicalTrials.gov record NCT01944683. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1b Study of Pharmacokinetic Interaction, Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure

Study identification

NCT ID
NCT01944683
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Acorda Therapeutics
Industry
Enrollment
22 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Other
  • GGF2 Drug
  • Midazolam Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2013
Primary completion
Apr 30, 2016
Completion
Jun 30, 2016
Last update posted
Jul 12, 2016

2013 – 2016

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
UCSD Medical Center La Jolla California 92037
Orange County Research Center Tustin California 92780
Jacksonville Center for Clinical Research Jacksonville Florida 32216
Tulane University School of Medicine New Orleans Louisiana 70112
Duke Clinical Research Unit Durham North Carolina 27710
New Orleans Center for Clinical Research (NOCCR) Knoxville Tennessee 37920
Vanderbilt University Medical Center Nashville Tennessee 37232
Sentara Cardiovascular Research Institute Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01944683, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01944683 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →